Leeuw
Christopher Leeuw, Edmonton CA
Patent application number | Description | Published |
---|---|---|
20110167534 | METHOD OF ATTACHING TIES TO A MEDICAL GOWN AND A MEDICAL GOWN HAVING TIES SECURED IN ACCORDANCE WITH THE METHOD - A method of securing ties to a medical gown including providing a medical gown and associated ties made from a material that is compatible with ultrasonic welding, folding the ties prior to welding to provide more than one layer of tie material and welding the ties by ultrasonic welding through the more than one layer of tie material. | 07-14-2011 |
20120234327 | FACE MASK WITH TRUNCATED NOSEPIECE - A face mask which has a fabric body of folded filter material that defines an expandable face pocket, an interior face, an exterior face, a top edge, a bottom edge and opposed side edges. A bendable strip of metal defines a nosepiece that is centrally positioned between the opposed side edges along the top edge. The nosepiece has a length that is not less than 3.50 cm and not more than 6.00 cm, and a width that is not less than 0.30 cm and not more than 2.00 cm. Straps are used to secure the fabric body to a person's head. | 09-20-2012 |
Christopher Leeuw, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20140187859 | ENDOLUMINAL INTRODUCER - An introducer for use during endoscopic procedures provides insufflation, washing, and aspiration functions, and provides for the protection of the endoluminal surface during laparoscopic examination of an anastomosis or suture line following low anterior resection of the bowel. The introducer may be designed for the insertion of an endoscope capable of white light and/or near infra-red fluorescence imaging into the rectum for analysis of an anastomosis following low anterior resection of the bowel. | 07-03-2014 |
Dagobert M.de Leeuw, Eersel NL
Patent application number | Description | Published |
---|---|---|
20080254568 | Composition and Method of Forming a Device - The present invention provides a method of forming a semiconducting device comprising an organic semiconducting material, which method comprises: heating a composition comprising the organic semiconducting material to a temperature at or above the melting point or glass transition temperature of the composition to form a melt; cooling the melt to a temperature below the melting point or glass transition temperature of the composition; and wherein a first substance or object capable of inhibiting and/or preventing dewetting is adjacent the composition before or during heating, or the composition further comprises an agent capable of inhibiting and/or preventing dewetting. | 10-16-2008 |
Dan Leeuw, Fort Wayne, IN US
Patent application number | Description | Published |
---|---|---|
20110188212 | CONNECTION OF A SYSTEM MODULE TO AN ELECTRONIC DEVICE - A system is provided that is securable to an electronic device. The system includes a module with a connection port that is configured to connect with a corresponding connection port of the electronic device. A securing structure is securable to portions of first ends of the module and electronic device to facilitate attachment of the module alongside the electronic device. When the module is attached to the electronic device with the securing structure, a side surface of the module engages with a corresponding side surface of the electronic device and the connection port of the module connects with the corresponding connection port of the connection device to establish an electrical connection between the module and the electronic device. | 08-04-2011 |
Thomas Leeuw, Greifenberg DE
Patent application number | Description | Published |
---|---|---|
20090104279 | USE OF PAK INHIBITOR FOR THE TREATMENT OF A JOINT DISEASE - The invention refers to the use of a p21-activated kinase (PAK) inhibitor as a target protein for the discovery of a PAK inhibitor as a medicament for the treatment of a joint disease. | 04-23-2009 |
20100167275 | Potassium channel mutants of the yeast Saccharomyces cerevisiae and their use for screening eukaryotic potassium channels - The invention relates to processes for identifying inhibitors and activators of eukaryotic potassium channels, in which a mutated | 07-01-2010 |
Thomas Leeuw, Eltville DE
Patent application number | Description | Published |
---|---|---|
20110257021 | USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER - The present invention refers to the use of the Mst protein or a nucleotide sequence coding for the Mst protein for the treatment of a thromboembolic disorder and to a method of screening a modulator of the Mst protein or the nucleotide sequence coding for the Mst protein. | 10-20-2011 |
20120065078 | METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES - The present invention refers to a method for the in vitro or in vivo diagnosis of cardiovascular diseases, in particular high blood pressure, stenosis, vessel occlusion and/or other thrombotic events, wherein the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein of a sample of a person is determined as well as to the use of ARK2 for the development and/or production of a medicament for treating a cardiovascular disease. | 03-15-2012 |
20140296169 | ISOTHIAZOLOPYRIDINE-2-CARBOXAMIDES AND THEIR USE AS PHARMACEUTICALS - The present disclosure relates to substituted isothiazolo[5,4-b]pyridine-2-carboxamides of the formula I, | 10-02-2014 |
Thomas Leeuw, Frankfurt Am Main DE
Patent application number | Description | Published |
---|---|---|
20090149375 | USE OF THE MST PROTEIN FOR THE TREATMENT OF A THROMBOEMBOLIC DISORDER - The present invention refers to the use of the Mst protein or a nucleotide sequence coding for the Mst protein for the treatment of a thromboembolic disorder and to a method of screening a modulator of the Mst protein or the nucleotide sequence coding for the Mst protein. | 06-11-2009 |
20090239218 | METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES - The present invention refers to a method for the in vitro or in vivo diagnosis of cardiovascular diseases, in particular high blood pressure, stenosis, vessel occlusion and/or other thrombotic events, wherein the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein of a sample of a person is determined as well as to the use of ARK2 for the development and/or production of a medicament for treating a cardiovascular disease. | 09-24-2009 |